Royal College of Surgeons in Ireland
|As first author||4|
|As last author||30|
Fergal J O'Brien(21)
Noel G McElvaney(11)
Catherine M Greene(9)
Garry P Duffy(9)
Erica G Tierney(7)
Caroline A Jefferies(6)
Joanne M Ramsey(5)
P J Gallagher(5)
Caroline M Curtin(5)
Paul J McKiernan(5)
... and 62 others
These arethe13 unique sources for Sally-Ann Cryan's 67 publications. A single publication may appear in multiple sources. Click on a name or publication count to see the publications for a particular source.
|Ireland -> Dublin City University||1|
|Ireland -> Dublin City University -> PubMed||1|
|Ireland -> Dublin Institute of Technology||2|
|Ireland -> Dublin Institute of Technology -> PubMed||1|
|Ireland -> Maynooth University||1|
|Ireland -> Maynooth University -> PubMed||1|
|Ireland -> National University of Ireland Galway||2|
|Ireland -> National University of Ireland Galway -> PubMed||2|
|Ireland -> Royal College of Surgeons in Ireland||56|
|Ireland -> Royal College of Surgeons in Ireland -> PubMed||38|
|Ireland -> Trinity College Dublin||4|
|Ireland -> Trinity College Dublin -> PubMed||2|
|Ireland -> University College Dublin||2|
A composite scaffold for use as a tissue engineering implant A composite scaffold for use in tissue engineering applications comprises a porous scaffold matrix comprising at least an organic material, a first microparticle preparation distributed in the scaffold matrix, and a second microparticle preparation distributed in the scaffold matrix. The first microparticle preparation comprises microparticles having a first polymeric microparticle matrix and a first active agent within the matrix such that the first active agent is capable of being released from the microparticle matrix/scaffold at a controlled rate. The second microparticle preparation comprises microparticles having a second microparticle matrix and a second active agent within the matrix such that the second active agent is capable of being released from the second microparticle matrix/scaffold at a controlled rate.
A microparticle preparation suitable for pulmonary delivery of an active agent comprises solid particles having a three-dimensional matrix structure and an active agent entrapped and dispersed throughout the three dimensional matrix structure. The particles having a Mass Median Aerodynamic Diameter (MMAD) of from 1 to 5[mu]m, and the three-dimensional matrix comprises a cross-linked polymer susceptible to degradation by human neutrophil elastase. The three dimensional matrix may comprise an interpenetrating network of a polymeric protein and a cross-linked polysaccharide polymer. Methods for producing the microparticles are also described.
Clicking through these tabs will give you a wealth of further insights into this expert through their commonly used topics, the evolution of their expertise, their collaborators and their publications.
Here is a quick breakdown of this expert's publication history
If this is the expert you have been looking for, simply click here to make contact.